Related Experiment Videos
Malignant histiocytosis--a clinicopathologic study of 5 cases
Insights
Malignant histiocytosis is a rare disorder. This study reviewed 5 cases, noting rapid progression and poor outcomes despite chemotherapy, highlighting diagnostic challenges.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Malignant histiocytosis (MH) is a rare hematologic neoplasm characterized by proliferation of atypical histiocytes.
- Understanding the clinico-pathological spectrum of MH is crucial for timely diagnosis and management.
Observation:
- A retrospective review of 5 patients diagnosed with malignant histiocytosis between 1980 and 1983.
- Patients ranged in age from 18 to 73 years.
- Diagnostic confirmation involved bone marrow, liver, spleen, or lymph node biopsies.
Findings:
- Detailed hematological, cytological, and histopathological findings were documented.
- Three out of five patients experienced rapid mortality despite cytotoxic chemotherapy.
- One patient was lost to follow-up; another survived 3 months post-diagnosis.
Implications:
- The study underscores the aggressive nature and poor prognosis of malignant histiocytosis.
- Challenges in the differential diagnosis of MH are highlighted.
- Further research into effective therapeutic strategies for MH is warranted.
Abstract:
The clinico-pathological features of 5 patients with malignant histiocytosis aged 18 years to 73 years seen over a three year period from 1980 to 1983 at the Department of Haematology Singapore General Hospital were studied. Haematological, cytological and histopathological findings of the disease are described. Diagnosis of malignant histiocytosis was established from biopsies of bone marrow, liver, spleen or lymph nodes. Three out of the 5 patients died rapidly after diagnosis despite cytotoxic chemotherapy. One patient was lost to follow up while another is alive surviving so far for 3 months since diagnosis. The differential diagnosis of malignant histiocytosis is also discussed.